Latest / Flash Stock Reports (Video)
The Deadly Threat to PHX Stock's 99% Monopoly
PharmX Technologies (PHX.AX) stock analysis: 99% monopoly faces 129x multiple — buy or sell? 👉 Want this level of research on ANY COMPANY IN THE WORLD... for FREE? Check us out at: https://flash.stocksentinel.ai/?utm_source=rss_video&utm_medium=explainer_video&utm_campaign=freja_and_friends In this deep dive, we break down PharmX Technologies Limited (PHX.AX) and its strategic pivot to a high-margin transactional marketplace model and its landmark alliance with Sigma Healthcare. With shares trading at a premium Price-to-Sales multiple of 10.3x, the key question for investors is whether the…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.